Observational studyScientific reports2025
Sex-specific spirometry effects of adult COPD polygenic score in children with asthma.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability globally. While genetic and environmental risk factors are known, these insights have not yet resulted in individualized prevention strategies. Polygenic scores (PS) have enhanced our understanding of genetic risk and early-life lung function differences, but their applicability across diverse populations remains unclear. As such, we aimed evaluate whether a COPD PS captures population-wide risk or disproportionately affects sub-populations defined by ancestry or sex. This observational study assessed the association between a previously validated COPD PS and lung function in children with asthma, using spirometry results from children with asthma in the Center of Applied Genomics biorepository. Mixed-effects linear regression models were used to examine the relationship between PS and spirometry measures (FEV1 and FEV1/FVC), with stratified analyses by sex and ancestry. 25,477 spirometry results from 6336 patients were included. Population-wide, children in the high PS group had significantly lower FEV1/FVC z-scores compared to the low PS group (P = 0.0037, beta = - 0.11, 95% confidence interval [CI] - 0.18 to - 0.036). When stratified by sex, high PS was associated with lower FEV1/FVC z-scores in males (P = 0.0088, beta = - 0.14, 95% CI - 0.24 to - 0.035), but no significant effect was found in females. Ancestry-specific analysis revealed that males of European (EUR) ancestry with high PS had significantly lower FEV1 (P = 0.0035, beta = - 0.37, 95% CI - 0.63 to - 0.12) and FEV1/FVC z-scores (P = 0.00076, beta = - 0.35, 95% CI - 0.55 to - 0.15). No significant associations were observed in females with EUR ancestry or in African ancestry groups. Logistic regression analysis showed that high PS in males of EUR ancestry increased the odds of having an FEV1/FVC ratio below 0.7, a marker for COPD (P = 0.0074, OR = 2.01, 95% CI 1.19 to 3.31). This study demonstrates sex-specific effects of a COPD PS in pediatric asthma patients, with males of EUR ancestry at highest risk. The findings underscore the need to include diverse populations in genomic studies to improve the generalizability of PS for COPD prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.